Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

813 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply by Authors.
Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S, Stankiewicz E, Davies CR, Rajan P, Tipples K, Hines J, Chan PY, Campbell D, Wilkinson K, Kudahetti S, Shamash J, Oliver T, Berney D, Shaw G, Lu YJ. Xu L, et al. Among authors: oliver t. J Urol. 2020 Jan;203(1):81-82. doi: 10.1097/01.JU.0000602796.11621.76. Epub 2019 Oct 3. J Urol. 2020. PMID: 31580196 No abstract available.
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.
Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S, Stankiewicz E, Davies CR, Rajan P, Tipples K, Hines J, Chan PY, Campbell D, Wilkinson K, Kudahetti S, Shamash J, Oliver T, Berney D, Shaw G, Lu YJ. Xu L, et al. Among authors: oliver t. J Urol. 2020 Jan;203(1):73-82. doi: 10.1097/JU.0000000000000475. Epub 2019 Aug 7. J Urol. 2020. PMID: 31389764
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.
Guo T, Wang Y, Jia J, Mao X, Stankiewicz E, Scandura G, Burke E, Xu L, Marzec J, Davies CR, Lu JJ, Rajan P, Grey A, Tipples K, Hines J, Kudahetti S, Oliver T, Powles T, Alifrangis C, Kohli M, Shaw G, Wang W, Feng N, Shamash J, Berney D, Wang L, Lu YJ. Guo T, et al. Among authors: oliver t. Front Cell Dev Biol. 2021 Jan 7;8:602493. doi: 10.3389/fcell.2020.602493. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33490068 Free PMC article.
A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population.
Marzec J, Mao X, Li M, Wang M, Feng N, Gou X, Wang G, Sun Z, Xu J, Xu H, Zhang X, Zhao SC, Ren G, Yu Y, Wu Y, Wu J, Xue Y, Zhou B, Zhang Y, Xu X, Li J, He W, Benlloch S, Ross-Adams H, Chen L, Li J, Hong Y, Kote-Jarai Z, Cui X, Hou J, Guo J, Xu L, Yin C, Zhou Y, Neal DE, Oliver T, Cao G, Zhang Z, Easton DF, Chelala C; PRACTICAL Consortium; CHIPGECS Group; Al Olama AA, Eeles RA, Zhang H, Lu YJ. Marzec J, et al. Among authors: oliver t. Oncotarget. 2016 Apr 19;7(16):21393-403. doi: 10.18632/oncotarget.7250. Oncotarget. 2016. PMID: 26881390 Free PMC article.
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.
Kudahetti SC, Fisher G, Ambroisine L, Prowse D, Kattan MW, Foster CS, Møller H, Oliver T, Fletcher A, Cooper C, Reuter V, Scardino P, Cuzick J, Berney DM; Transatlantic Prostate Group. Kudahetti SC, et al. Among authors: oliver t. Pathology. 2010;42(6):519-23. doi: 10.3109/00313025.2010.508788. Pathology. 2010. PMID: 20854069
The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.
Shan L, Ambroisine L, Clark J, Yáñez-Muñoz RJ, Fisher G, Kudahetti SC, Yang J, Kia S, Mao X, Fletcher A, Flohr P, Edwards S, Attard G, De-Bono J, Young BD, Foster CS, Reuter V, Moller H, Oliver TD, Berney DM, Scardino P, Cuzick J, Cooper CS, Lu YJ; Transatlantic Prostate Group. Shan L, et al. Among authors: oliver td. Prostate Cancer Prostatic Dis. 2010 Jun;13(2):117-25. doi: 10.1038/pcan.2010.2. Epub 2010 Feb 23. Prostate Cancer Prostatic Dis. 2010. PMID: 20177423 Free PMC article.
813 results